1. Medtech Insight
  2. >>Geography
  3. >>Asia

India's Device Price Cap Storm Rages On: New Stent Cap And Spotlight On Catheter Trade Margins

 
• By Anju Ghangurde

India’s medical device pricing storm looks unlikely to abate any time soon, with another round of price caps on stents being enforced. The spotlight is also shining on the sharp variances in trade margins for catheters in the country.

fishing boat giant wave storm rogue wave

India’s apex pricing regulator, the National Pharmaceuticals Pricing Authority , has tweaked prices of stents yet again – this time capping prices of drug-eluting stents, including metallic DES and bioresorbable vascular scaffoldBVS)/biodegradable stents, at INR27,890 ($433.82), down from INR29,600, while upping, albeit marginally, the prices of bare-metal stents to INR7,660, from INR7,260.

The regulator has capped trade margins for stents and also highlighted the seemingly unreasonable margins on cardiac catheters used during...

Welcome to Medtech Insight

Create an account to read this article

Already a subscriber?

More from Asia

FDA Greenlights Expanded Use Of Boston Scientific’s Pulse Field Ablation System

 
• By Brian Bossetta

A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.

South Korean Health Ministry Sees Benefits Of Pre-Regulatory Review

 
• By Jung Won Shin

A system of pre-regulatory review consultations for innovative drugs and devices in South Korea has contributed to the accelerated development of such products.

FDA Blocks Some Olympus Endoscopes From Entering US

 
• By Brian Bossetta

After multiple warning letters and safety communications, the US FDA has decided to block the import of certain endoscopes from Olympus. In total, the agency’s action pertains to 58 device models manufactured by the Japanese firm used in urinary, respiratory, abdominal and pelvic procedures.

New EU Rules Limit Chinese Participation In Medtech Procurement

 
• By Amanda Maxwell

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.

More from Geography